Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model
2010
Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome
2015 StandoutNobel
Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection
2021 StandoutNobel
Messenger RNA-Based Vaccines Against Infectious Diseases
2020 StandoutNobel
COVID-19-neutralizing antibodies predict disease severity and survival
2020
Influenza vaccine effectiveness among 50–64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003–2004
2006
Should coronary artery bypass graft surgery patients with mild or moderate aortic stenosis undergo concomitant aortic valve replacement?
2004
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
Lipid nanoparticles for mRNA delivery
2021 Standout
Variability of Cost-Effectiveness Estimates for Pharmaceuticals in Western Europe: Lessons for Inferring Generalizability
2005
Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitope
2009
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
2019
Vaccination with Messenger RNA: A Promising Alternative to DNA Vaccination
2020 StandoutNobel
Recent advances in mRNA vaccine technology
2020 StandoutNobel
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice
2020 StandoutNobel
Maternity Satisfaction Studies and Their Limitations: “What Is, Must Still Be Best”
2003
Economic Burden of Heart Failure in??the Elderly
2008
Vaccine adjuvants – understanding molecular mechanisms to improve vaccines
2014 StandoutNobel
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
2013 Standout
Factors that may impact on immunosenescence: an appraisal
2010
Immunogenicity of a Monovalent 2009 Influenza A (H1N1) Vaccine in an Immunocompromised Population: A Prospective Study Comparing HIV-Infected Adults with HIV-Uninfected Adults
2010
Traumatic spinal cord injury
2017 Standout
Trivalent Inactivated Influenza Vaccine in African Adults Infected With Human Immunodeficient Virus: Double Blind, Randomized Clinical Trial of Efficacy, Immunogenicity, and Safety
2010
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
2021 Standout
The importance of reciprocity in relationships between community-based midwives and mothers
2006 Standout
Influenza Vaccination in the Organ Transplant Recipient: Review and Summary Recommendations
2011
Neurogenic bladder in spinal cord injury patients
2015
Nanomaterial Delivery Systems for mRNA Vaccines
2021 StandoutNobel
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
2009 Standout
Enhanced SARS-CoV-2 neutralization by dimeric IgA
2020 StandoutNobel
Caregivers’ contributions to heart failure self-care: A systematic review
2014 Standout
Vaccinating HIV patients: focus on human papillomavirus and herpes zoster vaccines.
2013 StandoutNobel
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Design and Characterization of Stabilized Derivatives of Human CD4D12 and CD4D1
2011 StandoutNobel
Influenza Hemagglutination-Inhibition Antibody Titer as a Correlate of Vaccine-Induced Protection
2011
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Cross‐reactive humoral responses to influenza and their implications for a universal vaccine
2013
Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine
2022 StandoutNobel
Works of James Piercy being referenced
Immunogenicity and protective efficacy of influenza vaccination
2004
An Economic Analysis of the Survival and Ventricular Enlargement (SAVE) Study
1997
Short postnatal hospital stay: implications for women and service providers
1997
Impact of urinary incontinence on health-related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivity
2014